IL85436A - - Google Patents

Info

Publication number
IL85436A
IL85436A IL85436A IL8543688A IL85436A IL 85436 A IL85436 A IL 85436A IL 85436 A IL85436 A IL 85436A IL 8543688 A IL8543688 A IL 8543688A IL 85436 A IL85436 A IL 85436A
Authority
IL
Israel
Application number
IL85436A
Other versions
IL85436A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL85436A0 publication Critical patent/IL85436A0/xx
Publication of IL85436A publication Critical patent/IL85436A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL85436A 1987-02-18 1988-02-16 Piperazinecarboxylic acid,its preparation and pharmaceutical compositions containing it IL85436A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (2)

Publication Number Publication Date
IL85436A0 IL85436A0 (en) 1988-07-31
IL85436A true IL85436A (fr) 1992-12-01

Family

ID=10612501

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85436A IL85436A0 (en) 1987-02-18 1988-02-16 Piperazinecarboxylic acid,its preparation and pharmaceutical compositions containing it

Country Status (28)

Country Link
JP (1) JPH0723387B2 (fr)
KR (1) KR960015190B1 (fr)
AT (1) AT391320B (fr)
AU (1) AU613009B2 (fr)
BE (1) BE1002427A3 (fr)
CA (1) CA1327799C (fr)
CH (1) CH675125A5 (fr)
CY (1) CY1739A (fr)
DE (1) DE3804936C2 (fr)
DK (1) DK168441B1 (fr)
ES (2) ES2011319A6 (fr)
FI (1) FI86733C (fr)
FR (1) FR2610932B1 (fr)
GB (2) GB8703749D0 (fr)
GR (1) GR1002471B (fr)
HK (1) HK142093A (fr)
HU (2) HU199858B (fr)
IE (1) IE59098B1 (fr)
IL (1) IL85436A0 (fr)
IT (1) IT1219447B (fr)
LU (1) LU87129A1 (fr)
MY (1) MY103206A (fr)
NL (1) NL8800412A (fr)
NZ (1) NZ223529A (fr)
PH (1) PH25512A (fr)
PT (1) PT86776B (fr)
SE (1) SE467256B (fr)
ZA (1) ZA881146B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
JPH11508761A (ja) * 1995-05-08 1999-08-03 ロンザ アーゲー Ｒ−α−ピペラジンカルボン酸およびＳ−α−ピペラジンカルボキサミドを製造する生物工学的方法
US6071915A (en) 1997-05-12 2000-06-06 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (ja) 2006-11-08 2008-05-29 Nec Electronics Corp 半導体装置およびオーディオプロセッサチップ
EP3427729A1 (fr) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probénécide destiné à être utilisé dans le traitement de maladies, troubles ou états épileptiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (fr) * 1984-04-17 1989-01-10 Jeffrey C. Watkins Derives de substitution en 4 d'acides piperazine-2- carboxyliques

Also Published As

Publication number Publication date
IE59098B1 (en) 1994-01-12
SE8800541D0 (sv) 1988-02-17
FI86733B (fi) 1992-06-30
CH675125A5 (fr) 1990-08-31
CA1327799C (fr) 1994-03-15
PT86776B (pt) 1992-05-29
KR880009944A (ko) 1988-10-06
GB8803438D0 (en) 1988-03-16
NZ223529A (en) 1991-02-26
AU613009B2 (en) 1991-07-25
DE3804936C2 (de) 1997-02-13
IL85436A0 (en) 1988-07-31
MY103206A (en) 1993-05-29
JPH0723387B2 (ja) 1995-03-15
GB2201676A (en) 1988-09-07
GR880100084A (el) 1988-12-16
FR2610932A1 (fr) 1988-08-19
IT8847631A0 (it) 1988-02-12
SE467256B (sv) 1992-06-22
DE3804936A1 (de) 1988-09-01
DK168441B1 (da) 1994-03-28
FI880744A (fi) 1988-08-19
ES2011319A6 (es) 1990-01-01
CY1739A (en) 1995-10-20
BE1002427A3 (fr) 1991-02-05
ATA36788A (de) 1990-03-15
ZA881146B (en) 1989-10-25
HUT49361A (en) 1989-09-28
GB2201676B (en) 1991-01-02
HU199858B (en) 1990-03-28
FR2610932B1 (fr) 1990-11-16
AU1175888A (en) 1988-08-25
ES2021904A6 (es) 1991-11-16
LU87129A1 (fr) 1988-09-20
HK142093A (en) 1994-01-07
HU211269A9 (en) 1995-11-28
FI86733C (fi) 1992-10-12
GR1002471B (el) 1996-11-15
AT391320B (de) 1990-09-25
DK79688D0 (da) 1988-02-16
PH25512A (en) 1991-07-24
PT86776A (pt) 1988-03-01
DK79688A (da) 1988-08-19
SE8800541A (fr) 1988-08-19
IT1219447B (it) 1990-05-18
KR960015190B1 (ko) 1996-11-01
NL8800412A (nl) 1988-09-16
IE880413L (en) 1988-08-18
GB8703749D0 (en) 1987-03-25
FI880744A0 (fi) 1988-02-17
JPS63203691A (ja) 1988-08-23

Similar Documents

Publication Publication Date Title
DE3866348D1 (fr)
DE8700968U1 (fr)
DE8701393U1 (fr)
DE3871524D1 (fr)
DE8703422U1 (fr)
DE8700310U1 (fr)
DE8703111U1 (fr)
DE8701154U1 (fr)
DE8702068U1 (fr)
DE8701753U1 (fr)
DE8701682U1 (fr)
DE8701175U1 (fr)
DE8700020U1 (fr)
DE3880850T2 (fr)
DE8700645U1 (fr)
DE8702461U1 (fr)
DE8700262U1 (fr)
DE8703469U1 (fr)
DE8701352U1 (fr)
DE8712123U1 (fr)
DE8702130U1 (fr)
DE8700977U1 (fr)
DE8702512U1 (fr)
DE8700600U1 (fr)
DE8702374U1 (fr)

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
RH Patent void
MM9K Patent not in force due to non-payment of renewal fees